Last reviewed · How we verify
Pf-07853578 (pf-07853578)
At a glance
| Generic name | pf-07853578 |
|---|---|
| Sponsor | Pfizer |
| Drug class | Small molecule inhibitor |
| Target | [specific protein] |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Indication 1
- Indication 2
Pipeline indications
Common side effects
Drug interactions
- Warfarin
- Aspirin
- Pentobarbital
- Phenobarbital
- Rivaroxaban
- Apixaban
- Dabigatran
- Clopidogrel
- Ticagrelor
- Prasugrel
- Cilostazol
- Dipyridamole
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |